2011
DOI: 10.1056/nejmicm1005598
|View full text |Cite
|
Sign up to set email alerts
|

Facial Angiofibromas Associated with Tuberous Sclerosis

Abstract: A 29-year-old woman presented with a long-standing history of yellow-orange papules on her nose and cheeks, skin-colored papules at the proximal nail fold of several toes, and a skin-colored plaque on her back. These findings were diagnosed as facial angiofibromas, periungual fibromas, and a shagreen patch, respectively. They are characteristic of tuberous sclerosis, an autosomal dominant disorder in which mutations in tumor suppressor gene TSC1 or TSC2 result in the formation of benign hamartomas throughout t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
4
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 0 publications
1
4
0
Order By: Relevance
“…Given the serious adverse effects of rapamycin-based drugs when administered systemically to adult and pediatric patients [18], [19], systemic treatments with rapamycin for even large hemangiomas is not advisable. However, recent efforts to develop and clinically test topical rapamycin-based therapy for cutaneous facial angiofibromas [20], the benign tumors seen in patients with tuberous sclerosis [21], may provide a basis for considering topical cutaneous rapamycin treatment also for infantile hemangiomas. The outcome of randomized double blind Phase I clinical trials for patients with tuberous sclerosis [20] will provide a useful guide for further efforts along this line.…”
Section: Discussionmentioning
confidence: 99%
“…Given the serious adverse effects of rapamycin-based drugs when administered systemically to adult and pediatric patients [18], [19], systemic treatments with rapamycin for even large hemangiomas is not advisable. However, recent efforts to develop and clinically test topical rapamycin-based therapy for cutaneous facial angiofibromas [20], the benign tumors seen in patients with tuberous sclerosis [21], may provide a basis for considering topical cutaneous rapamycin treatment also for infantile hemangiomas. The outcome of randomized double blind Phase I clinical trials for patients with tuberous sclerosis [20] will provide a useful guide for further efforts along this line.…”
Section: Discussionmentioning
confidence: 99%
“…6 Dome-shaped papules on the skin from forehead to the bridge of the nose and cheeks are a usual manifestation of angiofibroma that is mostly found in tuberous sclerosis. 7 Dessinioti et al presented that a red face is not always equal to rosacea. 6 In confirmation of their study, we presented a patient with cutaneous presentations mimicking rosacea and angiofibroma due to the lesions limited to the center of the face and eventual diagnosis of DLE.…”
Section: Introductionsupporting
confidence: 58%
“…Dome‐shaped papules on the skin from forehead to the bridge of the nose and cheeks are a usual manifestation of angiofibroma that is mostly found in tuberous sclerosis …”
Section: Introductionmentioning
confidence: 99%
“…This case report describes the successful reduction of a rhinophyma in a patient affected by TSC. Disfigurement of the nose due to proliferation of angiofibroma in TSC patients was repeatedly reported [ 11 ], [ 13 ], [ 16 ], [ 30 ]. However, following the case report of Bernstein in 1978 [ 2 ] this is likely to be the second description of a rhinophyma in conjunction with an angiofibroma (adenoma sebaceum).…”
Section: Discussionmentioning
confidence: 99%